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Associations of the intestinal microbiome with the complement
system in neovascular age-related macular degeneration
Denise C. Zysset-Burri 1,2✉, Irene Keller2,3, Lieselotte E. Berger1, Carlo R. Largiadèr4, Matthias Wittwer5, Sebastian Wolf 1,2 and
Martin S. Zinkernagel 1,2
Age-related macular degeneration (AMD) is a leading cause of severe vision loss in the aged population. The etiology of AMD is
multifactorial including nutritional factors, genetic variants mainly in the complement pathway, environmental risk factors and
alterations in the intestinal microbiome. However, it remains unexplored whether there is an interdependency of these factors
leading to the development of AMD. To investigate this issue, a shotgun metagenomics analysis of 57 neovascular AMD and 58
healthy controls as well as of 16 complement C3-deficient mice and 16 wildtypes was performed. Whereas the class Negativicutes
was more abundant in patients, the genus Oscillibacter and species Bacteroides had a significantly higher prevalence in persons
without AMD. Similar taxonomic features were identified that distinguished wildtype mice from C3-deficient mice. Moreover,
several purine signaling pathways were associated with both, neovascular AMD and C3 deficiency. While SNPs within the
complement factor B gene were more abundant in controls, SNPs within the high temperature requirement A serine peptidase 1 and
complement factor H (CFH) genes were associated with neovascular AMD. Using a classification model, Negativicutes was identified
as a potential biomarker for AMD and furthermore, it positively correlated with CFH. This study suggests an association between the
intestinal microbiome and the complement system in neovascular AMD.
npj Genomic Medicine            (2020) 5:34 ; https://doi.org/10.1038/s41525-020-00141-0
INTRODUCTION
Age-related macular degeneration (AMD) is the most frequent
cause of blindness among older people in developed countries1.
AMD has become a significant economic and social burden on
public health1 and its prevalence is projected to grow by 50% in
the next decades2. The early stage of AMD results in accumulation
of extracellular material underneath the retina, called drusen.
Drusen are a sign of impaired retinal pigment epithelium (RPE)
function and disruption of the metabolic transport between RPE
and choroid3. Whereas the intermediate stage of AMD is
characterized by larger drusen, the late stages are characterized
by either choroidal neovascularization (CNV) in the exudative form
or geographic atrophy in the atrophic form of AMD4. The
pathogenesis of AMD is multifactorial and is thought to be a
combination of oxidative stress, impaired RPE function, increased
apoptosis, and aberrant immune system activation5.
Despite major research efforts, treatment options for early and
intermediate AMD are only very limited. Smoking is the strongest
modifiable risk factor for AMD, resulting in oxidative stress,
ischemia, hypoxia, and ultimately development of CNV. Other
environmental risk factors are sunlight exposure6,7 and obesity8.
To date, the only factor that has been shown to be protective is a
healthy diet, rich in omega-3 fatty acids, lutein, zeaxanthin, and
antioxidants, consistent with the Age-Related Eye Disease Study 2
(AREDS2) formulation9. Therefore, preventative strategies target-
ing nutritional intake to avoid the development of AMD seem to
be most promising9–14. Recently, we have shown that composi-
tional and functional features of the intestinal microbiome may
have an impact on the development and progression of AMD15.
Moreover, in an animal model, it has been shown that
modifications in the intestinal microbiome resulted in exacerba-
tion of CNV16.
In addition to the effect of modifiable environmental risk
factors, genetic polymorphisms in genes such as in complement
factor H (CFH) may be linked with AMD17. Genetic polymorphisms
in components of the complement system refer to the potential
role of local inflammation and complement regulation in the
pathogenesis of AMD. Moreover, since toll-like receptors (TLRs)
recognize microbe-specific molecules and are expressed on
various cells along the gastrointestinal tract, they may be crucial
in signaling between the immune system and the microbiota.
Moreover, the complement system is a key part of the innate
immune system operating via TLR signaling. When over-activated
or de-regulated, the complement becomes a major link between
infection and inflammation with profound involvement in
inflammatory and degenerative diseases such as AMD18. In this
study, we investigated gut microbiome alterations in patients with
neovascular AMD and screened for associations between the
intestinal microbiome and the complement system.
RESULTS
Taxonomic and functional characterization of the intestinal
microbiome in AMD patients and healthy controls
In total, 115 stool samples were sequenced from 57 neovascular
AMD patients and 58 age- and sex-matched healthy controls. The
AMD patients and controls were similar for gender, age at
collection, smoking habit and BMI (p > 0.05, Table 1). A total of 2.8
billion 100 bp paired-end reads with an average insert size of
350 bp were generated, with an average of 24.3 ± 9.3 (s.d.) million
reads per sample. After trimming and filtering, we kept about
1Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. 2Department for BioMedical Research, University of Bern, Bern,
Switzerland. 3Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland. 4Department of Clinical Chemistry, Inselspital, Bern
University Hospital, University of Bern, Bern, Switzerland. 5Spiez Laboratory, Federal Office for Civil Protection, Austrasse, Spiez, Switzerland. ✉email: denise.zysset@insel.ch
www.nature.com/npjgenmed
Published in partnership with CEGMR, King Abdulaziz University
1
2
3
4
5
6
7
8
9
0
()
:,;
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
6
8
3
9
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
2.5 billion non-human high-quality reads, with an average of
21.5 ± 8.5 (s.d.) million reads per sample. We identified 834 taxa,
the majority of which were bacterial with 98.8 ± 8.1% (s.d.). The
phyla Firmicutes (40.4%) and Bacteroidetes (41.1%) dominated the
microbiome composition (Fig. 1). Bacteroidia (41.1%) and Clostridia
(37.1%) were the most abundant classes, and Bacteroides (16.5%),
Alistipes (13.0%), and Subdoligranulum (11.9%) the most abundant
genera in the cohort, consistent with previous observations19,20.
Arumugam et al.19 suggested that the human intestinal
microbiome can be separated into three distinct enterotypes
according to microbial composition. To cluster the AMD patients
and control samples into enterotypes, we used the PAM algorithm
applying Jensen–Shannon distance for relative genus abundances
(Fig. 2). The optimal number of clusters was three according to the
CH index (Fig. 2b). Between-class-analysis was applied to divide
the samples into three enterotypes. (Fig. 2a). The following genera
characterized the individual enterotypes: in enterotype 1 Bacter-
oides was present to a relatively high level, Prevotella in enterotype
2, and Escherichia was indicative for enterotype 3 (Fig. 2c).
However, since no association between the enterotypes and the
disease status was found (p > 0.05, Fisher’s exact test), the samples
appear to be uniformly distributed across the three enterotypes.
A principal component analysis (PCA) using the health status as
grouping variable confirmed that the patient group is separated
from the control group based on differences in microbial species
abundances (p= 0.001, PERMANOVA analysis with nrepet =
10,000, Fig. 1c). However, the two groups could not be separated
by differences in relative abundances of functional profiles (p=
0.31, PERMANOVA analysis with nrepet = 10,000, Fig. 3a). To
further examine features of the intestinal microbiome in AMD
patients, we compared the relative abundances of taxa between
patients and controls, showing that the class Negativicutes was
more abundant in patients (q= 0.0038) and the genus Oscillibacter
(q= 0.094) and Bacteroides species (q= 0.045, MaAsLin) were
more abundant in controls (Fig. 1d). Moreover, patient’s intestinal
microbiomes were enriched in genes of the purine ribonucleo-
sides degradation pathway (q= 0.079, MaAsLin, Fig. 3b).
Identification of AMD patients based on the intestinal microbiome
To illustrate the potential diagnostic value of the intestinal
microbiome for AMD, a species-based classifier was used in an
attempt to predict AMD samples among a mixture of samples
from patients and healthy controls. Based on the relative species
abundance profile from MetaPhlAn, a classification model was
constructed using linear shrinkage discriminant analysis and
features were ranked according to their correlation-adjusted t
(cat) scores. A graphical visualization of the cat scores is provided
in Fig. 4a. The blue bars in this figure indicate the ability of a
potential biomarker to discriminate between AMD patients and
controls in the prediction model. A positive cat score implies that
the taxon is over-represented in AMD, whereas a negative score
represents an over-represented taxon in controls. The minimum
error was reached with seven features (Fig. 4b), which were
selected as potential biomarkers, including the class Negativicutes,
the order Selenomonadales and the species Phascolarctobacterium,
Bacteroides cellulosilyticus, Sutterella wadsworthensis, Bifidobacter-
ium longum, and Bacteroides caccae.
Association between single nucleotide polymorphisms and AMD
Out of the genetic polymorphisms previously shown to be associated
with risk for AMD21–34, single nucleotide polymorphisms rs800292
(p= 0.0012), rs1410996 (p= 0.00019) and rs1061170 (p= 0.000064)
within the complement factor H (CFH) gene and rs11200638
(p= 0.00012) within the high temperature requirement A serine
peptidase 1 (HTRA1) gene were associated with a higher risk for
having AMD in our cohort. However, rs12614 (p= 0.0057) within the
complement factor B (CFB) gene was inversely correlated with AMD in
the cohort (Fisher’s exact test, Table 2).
Association between the intestinal microbiome and clinical
metadata in the cohort
Next, we use multivariate association by linear models (MaAsLin)
to examine whether relative abundances of microbial taxa and
pathways were associated with demographic parameters or with
genetic risk factors for AMD (CFH1, CFH2, CFH3, and HTRA1,
Fig. 4c). A boosting step in the MaAsLin algorithm ensures that
only variables that are associated with the given taxon are
included in the linear model, implying that all associations found
by the modeling approach have been corrected for all other
confounding factors. For demographic parameters, age at
collection positively correlated with the species Bacteroides
uniformis, Odoribacter unclassified, and Eubacterium eligens and
negatively correlated with the superpathway of pyrimidine
ribonucleosides degradation (Fig. 3c; q < 0.2). There was no
association of sex, smoking habit, or BMI with the intestinal
microbiome in our cohort (q > 0.2). Bacteroides species and
Ruminococcus torques negatively correlated with CFH1 variants,
i.e., Bacteroides species and Ruminococcus torques were less
abundant in individuals possessing the SNP in the CFH1 gene.
The order Clostridiales positively correlated with CFH3 and
negatively correlated with CFH1 and CFH2 variants. The class
Negativicutes positively correlated with CFH3 (Fig. 4C). There was
no association of HTRA1 variants with the intestinal microbiome in
the cohort.
Taxonomic and functional characterization of the intestinal
microbiome in C3-deficient mice and wildtypes
In total, 64 stool samples were sequenced from 16 C3−/− mice and
16 C57BL/6 control mice (Table 3). A total of 1.9 billion 100 bp
paired-end reads with an average insert size of 350 bp were
generated, with an average of 31.2 ± 11.1 (s.d.) million reads per
sample. After trimming and filtering, we kept about 1.7 billion
non-murine high-quality reads, with an average of 27.3 ± 9.9 (s.d.)
million reads per sample. We identified 98 taxa, the majority of
which were bacterial with 96.8 ± 11.1% (s.d.). The phylum
Firmicutes or Bacteroidetes dominated the microbiome composi-
tion (Fig. 5a) in accordance with previous observations35.
A PCA showed that differences in microbial species and
functional feature abundances separated the C3−/− mice from
the wildtypes (p= 0.001, PERMANOVA analysis with nrepet =
10,000, Figs. 5c and 6a). To further examine features of the
intestinal microbiome in C3−/− mice, we compared the relative
abundances of taxa between C3-deficient mice and wildtypes,
showing that the phylum Firmicutes was more abundant in C3−/−
Table 1. Characteristics of study patients.
Feature Patients
(n= 57)
Controls
(n= 58)
p-value AMD
vs CTRL
Males (n (%)) 21 (36.8) 25 (43.1) 0.57a
Age (years) 75.4 ± 8.3 75.3 ± 8.1 0.92b
Current smoker (n (%)) 6 (10.5) 3 (5.2) 0.31a
Previous smoker (n (%)) 20 (35.1) 21 (36.2) 1.0a
BMI (kg/m2) 25.0 ± 4.5 26.0 ± 3.9 0.21b
Data are mean ± SD.
BMI body mass index, CTRL control, AMD age-related macular degeneration.
aFisher’s exact test.
bWelch’s t-test.
D.C. Zysset-Burri et al.
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mice (q < 0.2) and the phylum Bacteroidetes was more abundant in
wildtypes (q < 0.2; Fig. 5d). Based on a classification model using
shrinkage discriminant analysis and ranking features according to
cat scores, the phylum Firmicutes, the class and order Clostridia
and Clostridiales, respectively, as well as the genus Subdoligranu-
lum and an unclassified species of genus Subdoligranulum were
identified as potential biomarkers for C3 deficiency in mice
(Supplementary Fig. 1). Moreover, intestinal microbiomes of C3−/−
mice were enriched in genes of the 5-aminoimidazole
ribonucleotide biosynthesis pathways (q < 0.0001, MaAsLin, Fig.
6b). There was no association of sex or week at collection with the
intestinal microbiome in the cohort (q > 0.02).
DISCUSSION
Despite advances in the treatment of neovascular AMD, effective
preventative strategies of this disease are lacking. An association
of diet with development of advanced AMD has been shown in
Fig. 1 Diversity of the intestinal microbiome in AMD patients and healthy controls. Relative abundances of microbiota at phyla level in all
study subjects (a) and averaged for study groups (b). c Principal component analysis of microbial species abundance grouped patients and
controls separately, with PERMANOVA confirming a significant difference between the groups (p= 0.0018). d Relative abundances of taxa
associated with AMD (q-values after adjusting for false discovery rate). Mean value and standard deviation are shown. AMD age-related
macular degeneration; CTRL control.
D.C. Zysset-Burri et al.
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various studies (AREDS I and II). In this study, we investigated
associations between the intestinal microbiome and the comple-
ment system in neovascular AMD. Microbiota in AMD patients and
healthy controls was analyzed in terms of taxonomic and
functional profiles and correlated to clinical metadata and genetic
risk factors including SNPs in genes encoding for complement
factors. We identified several taxonomic and functional features of
the intestinal microbiome that differ between patients and
healthy controls in their relative abundance, suggesting that they
may be associated with the development of AMD. The genus
Oscillibacter and species Bacteroides were more abundant in
healthy controls relative to AMD patients. In contrast, the class
Negativicutes was more abundant in AMD patients compared to
controls. These results are consistent with previous studies,
reporting associations between several of these taxa and
AMD15,36. Moreover, patient’s intestinal microbiomes were
enriched in genes of the purine ribonucleosides degradation
pathway. Aberrant purine signaling pathways have been impli-
cated in immune dysregulation as occurred in the pathogenesis of
autoimmune diseases37. Although autoimmunity in terms of
autoantibody production is associated with a variety of ocular
diseases including AMD, the detailed triggers for ocular auto-
immunity are unknown38. The different functional feature
between patients and controls in our study suggests that immune
dysregulation in AMD may occur via purine signaling.
After smoking, obesity is the second most important environ-
mental risk factor for AMD39. Numerous studies have shown that a
higher relative abundance of Firmicutes and a lower Bacteroidetes
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Fig. 2 Enterotypes of the intestinal microbiome in AMD patients and healthy controls. a The intestinal microbiota was clustered into three
enterotypes at genus level, dominated by Bacteroides (enterotype 1), Prevotella (enterotype 2), and Escherichia (enterotype 3). Patients (n= 57)
and controls (n= 58) were denoted by squares (□) and triangles (Δ), respectively. b The optimal number of enterotypes was three as indicated
by the maximum Calinski–Harabasz (CH) index at three clusters. c Relative abundances of the dominant genera in the three enterotypes. Mean
value and standard deviation are shown. Blue is enterotype 1, purple is enterotype 2, and orange is enterotype 3.
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abundance are typically associated with obesity40. In a previous
study, we observed a shift of relative abundance in Firmicutes at the
expense of Bacteroidetes in AMD patients15. In this study, the class
Negativicutes belonging to the phylum Firmicutes was enriched in
AMD patients. Moreover, Bacteroides species belonging to the
phylum Bacteroidetes was more abundant in controls. Looking at the
prediction model in Fig. 4a, Negativicutes as well as the order
Selenomonadales, both belonging to the phylum Firmicutes, may be
identified as potential biomarkers for AMD. On the other hand,
Bacteroides species, especially including B. cellulosilyticus and B.
caccae, may have a protective effect on the development of AMD as
these species were more abundant in the control group. Taken
together, these results suggest an elevated Firmicutes to Bacter-
oidetes ratio, also at lower taxonomic levels in AMD patients
compared to healthy controls. These data are also consistent with
observations in mice, demonstrating that high-fat diets exacerbate
choroidal neovascularization, which is a hallmark of exudative AMD,
by increasing the relative abundance of Firmicutes36.
In addition to environmental risk factors, genetic risk factors
mostly associated with the complement system are involved in the
development of AMD. The first genome-wide association study
performed in 2005 revealed a high association between genetic
polymorphisms in complement factor H (CFH) and AMD41. This
genetic link was further extended by several studies showing an
association between AMD and other complement factors such as
complement component 3 (C3), complement component C2 (C2),
and complement factor B (CFB)42,43. In our cohort, while single
nucleotide polymorphisms (SNPs) within the CFH gene are
associated with a higher risk for developing AMD, SNP within the
CFB gene has a protective effect (Table 2). Furthermore, to assess
associations between the complement system and the intestinal
microbiome, both involved into the development of AMD,
microbiota of C3-deficient mice and wildtypes was analyzed in
terms of taxonomic and functional profile and correlated to clinical
metadata. Hoh Kam et al.44 showed that C3 deficiency in mice
negatively affect aged retinas in terms of retinal function,
inflammation and morphological features. Other publications have
shown that overexpression of C3 leads to pathology in the murine
retina including functional and morphological features observed in
AMD45. However, in our study, the intestinal microbiomes of C3-
deficient mice were enriched in genes of the 5-aminoimidazole
ribonucleotide biosynthesis pathways. Since 5-aminoimidazole
ribonucleotide is an intermediate of purine nucleotide biosynthesis
and purine signaling, in turn, may be involved in AMD pathogen-
esis, this pathway may be a key point in the interconnection
between the intestinal microbiome, the complement system
and AMD. Furthermore, while the phylum Firmicutes was more
abundant, the phylum Bacteroidetes was decreased in C3-deficient
mice compared to wildtypes (Fig. 5). Since Firmicutes was proposed
as potential biomarker for AMD, it may also contribute to the
development of AMD in C3-deficient mice. These results show that
the complement alters the intestinal microbiota composition in
mice and as such microbiota-derived nutrients, metabolites and
antigens within the host. This in turn may promote degenerative
diseases such as AMD. This association between the complement
system and the intestinal microbiome was further confirmed in
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Fig. 3 Functional profile of the intestinal microbiome in AMD patients and healthy controls. a Principal component analysis of functional
feature abundance did not separate patients from controls (p= 0.31, PERMANOVA). Relative abundances of pathway associated with AMD (b
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age-related macular degeneration; CTRL control.
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humans by the correlation of SNPs within the CFH gene with the
taxa Negativicutes, Clostridiales, Bacteroides species, and Rumino-
coccus torques (Fig. 4c). Clostridiales in particular was also identified
as potential biomarker for C3 deficiency in mice, thereby
highlighting the possible role of this taxon in the interconnection
between complement and microbiome. However, complement
factor H is the soluble inhibitor of the alternative pathway of
complement, mediating anti-inflammatory housekeeping functions
by protecting cells from complement activation. Thus, mutations in
the CFH gene result in uncontrolled complement activation, which
is involved in the pathogenesis of AMD46. Since Negativicutes,
which was proposed as potential biomarker for AMD (Fig. 4a),
positively correlated with CFH, it may influence the development
and/or progression of AMD via the regulation of the alternative
pathway of complement. Moreover, while the relative abundance
of Bacteroides species were proposed as potential biomarker for
controls and negatively correlated with CFH, they may be
protective for AMD. Thus, further investigation could aim at
modulating the intestinal microbiome of AMD patients with the
aim of decreasing the Firmicutes to Bacteriodetes ratio, thereby
potentially also regulate the complement pathway involved in
AMD pathogenesis. However, limitations of this study include the
lack of longitudinal data and the limited number of patients.
In conclusion, we found alterations of the intestinal microbiome
in AMD patients. While the phylum Firmicutes was more abundant
in patients with neovascular AMD, species Bacteroides may be
protective for AMD, both correlating with the genetic risk factor
CFH. These data point towards a possible interconnection
between the intestinal microbiome, the complement system and
the development of neovascular AMD. However, the data do not
allow to determine whether the altered intestinal microbiome is
the consequence of the disease or is involved in its pathogenesis
via uncontrolled activation of the complement system.
METHODS
Study design and recruitment
The study was approved by the Ethics Committee of the Canton of Bern
(ClinicalTrials.gov: NCT02438111). Study procedures followed the tenets of
the Declarations of Helsinki and the International Ethical Guidelines for
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D.C. Zysset-Burri et al.
6
npj Genomic Medicine (2020)    34 Published in partnership with CEGMR, King Abdulaziz University
Biomedical Research involving Human Subjects. Written consent was
obtained from all participants before study enrollment. Participants (n=
115) were recruited from the Department of Ophthalmology of the
University Hospital Bern (Inselspital), Switzerland. All participants were
Caucasian and were 50 years of age or older. They were subjected to an
ophthalmic examination including optical coherence tomography and
standard fundus color photography. Patients (n= 57) had clinically
confirmed active neovascular AMD. The control group (n= 58) was
selected to represent an age- and sex-matched group with no signs of
AMD. Participants with chronic inflammatory or gastrointestinal diseases
(including previous surgery in the gastrointestinal tract) or use of systemic
antibiotics within the last three months were excluded.
Metagenomic DNA sequencing and annotation
Stool samples were provided refrigerated to the study center within
16 hours after fecal output where they were immediately frozen at −20 °C.
Metagenomic DNA was isolated and sequenced as described in Zysset-
Burri et al.47. To exclude low-quality reads and reads mapping to human
DNA, the resulting 150 bp paired-end reads were quality filtered with
Trimmomatic v.0.3248 and mapped to the human reference genome hg19
using Bowtie2 v.2.2.449. For taxonomical annotation, the Metagenomic
Phylogenetic Analysis tool v.2.6.0 (MetaPhlAn2) and the marker database
v.2050 applying default settings were used. The relative abundances of
each taxonomic unit were calculated using Bowtie2 v.2.2.4 for alignment
followed by normalization of the total number of reads in each clade by
the nucleotide length of its marker. For functional annotation, the HMP
(Human Microbiome Project51) Unified Metabolic Analysis Network
(HUMAnN2 v.0.11.052) was used with default settings. In order to provide
a functional interpretation of the taxonomic profiles from MetaPhlAn2,
HUMAnN2 was run for each sample separately as described in Zysset-Burri
et al.47, finally resulting in a set of pathways including their abundances.
Genetic analysis of germline DNA
Genomic DNA was extracted from EDTA blood samples using a QIAamp
DNA Blood Midi Kit (Qiagen AG, Basel, Switzerland). To identify genetic risk
factors for AMD, 16 previously described SNPs were analyzed (Supple-
mentary Table 1). Real-time quantitative PCR (see below) was used for
allelic discrimination of all SNPs analyzed except for CFB (rs4151667,
rs12614, and rs641153), which was assessed by Sanger sequencing. This
locus was amplified using the Multiplex PCR Kit (Qiagen, Hombrechtikon,
Switzerland) with an initial 15 min denaturation step at 95 °C, followed by
35 amplification cycles (30 s at 94 °C, 90 s at 58 °C, 60 s 72 °C) and a final
10min extension at 72 °C. The following forward and reverse primers were
used: 5′-GGTCTAGGTCTGGAGTTTCAGC-3′ and 5′-TTGGTCTTGAGTCT
TCAGGGTG-3′. PCR products were purified using the QIAquick PCR
Purification Kit (Qiagen) and Sanger sequenced using the same primers
as used for PCR amplification. Bi-directional sequencing was carried out
using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Life Technolo-
gies, Zug, Switzerland) on a 3130xl Genetic Analyzer. Cycle Sequencing
was performed with an initial 1 min denaturation at 96 °C, followed by 25
amplification cycles (10 s at 96 °C, 5 s at 50 °C, 75 s 60 °C). Sequences were
aligned and compared to the reference sequences (NG_008191.1 and
NC_000006.12) using the Sequencer 5.0 software (Gene Codes Corpora-
tion, Ann Arbor, USA).
Pre-designed TaqMan® SNP genotyping assays (Applied Biosystems,
Foster City, CA, USA) were obtained for rs4420638, rs1061170, and
rs13278062. Custom designed TaqMan® assays (Assay-by-Design, Applied
Biosystems) were obtained for all other SNPs. Allelic discrimination was
performed on a 7500 Fast Real-Time PCR System (Applied Biosystems)
according to the manufacturer’s protocol.
Enterotyping
The samples were clustered based on relative genus abundances using
Jensen–Shannon distance and the partitioning around medoids (PAM)
Table 2. Single nucleotide polymorphisms in AMD.
Genes SNP A1 A2 F_A1 F_U p-value OR 95% CI FDR BH
C2 rs1883025 C G 0.018 0.052 0.28 0.34 (0.067, 1.72) 0.31
C3 rs4420638 C G 0.25 0.16 0.10 1.74 (0.91, 3.35) 0.25
CETP rs10490924 A C 0.34 0.35 0.89 0.93 (0.54, 1.61) 0.85
CFB1 rs4151667 A T 0.027 0.052 0.50 0.51 (0.13, 2.11) 0.51
CFB2 rs641153 T C 0.12 0.094 0.67 1.28 (0.55, 2.99) 0.76
CFB3 rs12614 A G 0.027 0.13 0.0057 0.19 (0.053, 0.67) 0.015
CFH1 rs800292 A G 0.24 0.082 0.0012 3.45 (2.31, 5.63) 0.0048
CFH2 rs1410996 A G 0.39 0.16 0.00019 3.21 (2.16, 4.85) 0.00091
CFH3 rs1061170 T C 0.60 0.34 0.000064 3.03 (1.89, 4.57) 0.00085
CFI rs10033900 C T 0.55 0.45 0.18 1.48 (0.87, 2.50) 0.31
COL8A1 rs13095226 C T 0.13 0.11 0.83 1.16 (0.52, 2.58) 0.85
HTRA1 rs11200638 A G 0.51 0.26 0.00012 2.97 (1.70, 5.20) 0.00085
LIPC rs10468017 T C 0.28 0.29 0.88 0.95 (0.53, 1.68) 0.85
TIMP3 rs9621532 C A 0.0091 0.034 0.37 0.26 (0.028, 2.34) 0.31
TNFRSF10A rs13278062 C A 0.41 0.5 0.18 0.69 (0.41, 1.17) 0.31
VEGF A rs1413711 T C 0.47 0.46 0.89 1.07 (0.63, 1.80) 0.85
A1 minor allele, A2 major allele, F_A1 frequency of A1 in AMD, F_U frequency of A1 in controls, FDR BH false discovery rate correction using the
Benjamini–Hochberg procedure, OR odds ratio for A1.
Table 3. Parameters of animal experiments.
Group Mouse Timepoints
(weeks) Sex (m/w)
Number
of mice
1 B6;129S4-C3tm1Crr/J 1 + 4 m 8
2 B6;129S4-C3tm1Crr/J 1 + 4 f 8
3 C57BL/6J 1 + 4 m 8
4 C57BL/6J 1 + 4 f 8 (6)
Two wildtype males were killed due to fighting activities before stool
sampling have been performed at week 4.
B6;129S4-C3tm1Crr/J complement factor C3-deficient mice, C57BL/6J
wildtypes.
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algorithm. The optimal number of clusters was calculated by the
Calinski–Harabasz (CH) index. Between-class-analysis (BCA), a particular
case of PCA, was used to visualize the taxonomic drivers of the clusters19.
Statistical analysis
Demographics were compared among groups applying either Welch’s
t-test (for age and BMI) or Fisher’s exact test (for sex and smoking, Table 1).
In order to identify differences in microbial abundances, the Wilcoxon rank
sum test was performed. To detect an association between enterotypes
and the disease status, Fisher’s exact test was applied using GraphPad
Prism version 7.04 (GraphPad software Inc.). p-values < 0.05 were
considered to be significant.
The association analyses between AMD and the SNPs were conducted
using Fisher’s exact test implemented in PLINK v.1.0753. Multiple testing
was corrected using Benjamini–Hochberg procedure. For subsequent
analysis, genotypes at each locus of each individual are coded as follows: 0
for major allele homozygous, 1 for heterozygous, and 2 for minor allele
homozygous.
R software (version 3.5.1) was used to perform other analyses. To provide
global analysis of microbial and pathway abundances between groups by
PCA, the R package ade454 was applied. PCA was done using scaled values
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Fig. 5 Diversity of the intestinal microbiome in C3-deficient mice and wildtypes. Relative abundances of microbiota at phyla level in all
mice (a) and averaged for groups (b). c Principal component analysis of microbial species abundance grouped C3-deficient mice and
wildtypes separately, with PERMANOVA confirming a significant difference between the groups (p= 0.001). Representative data of one
experiment is shown. d Relative abundances of taxa associated with C3 deficiency (q-values after adjusting for false discovery rate). Mean
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on relative abundances of microbial species identified by MetaPhlAn2 and
of pathways identified by HUMAnN2. A visualization of the individual
samples grouped by case and control is provided in Figs. 1c, 3a, 5c, and 6a.
To provide a p-value for separation, permutation multivariate analysis of
variance (PERMANOVA) using the R package vegan55 was assessed with
1000 permutations. Associations of microbial and functional abundances
with clinical metadata were analyzed using multivariate association by
linear models (MaAsLin)56 R package. Significant association was
considered below a q-value threshold of 0.20 after adjusting for false
discovery rate (FDR; Benjamini–Hochberg). For clinical metadata, the R
package corrplot was used for visualization of the data in a correlation
matrix (Fig. 4b). The R package sda provided the functionality for high-
dimensional linear discriminant analysis with feature selection. A species-
based classifier using the relative species abundance profile from
MetaPhlAn was trained using Stein-type shrinkage estimators and features
are ranked according to correlation-adjusted t (cat) scores to provide a set
of candidate biomarkers (Fig. 4a; Supplementary Fig. 1). The minimum
error was calculated by 10-fold cross-validation by the “rfcv” function of
the randomForest package with sequentially reduced numbers of features.
The optimal number of features was selected by cross-validation. The
model was tested on the testing set using this set of features and a
receiver operating characteristic (ROC) curve within the pROC package in R.
Mice
Adult (6–8 weeks of age) C3−/− mice on a C57BL/6 background (B6;129S4-
C3tm1Crr/J, n= 16) and C57BL/6 mice as controls (n= 16), both from
Jackson Laboratory (Bar Harbor, ME, USA), were used for this study. Mice
were housed in groups of four animals of the same gender under
temperature and humidity-controlled conditions in individually ventilated
cages giving sterile food and water ad libitum and exposed to 12:12 h light:
dark cycles. One and 4 weeks after arrival of the mice, feces were collected
and immediately frozen at −20 °C. At the end of the study, mice were
killed by carbon dioxide (CO2) inhalation. Metagenomic DNA was isolated
and sequenced as described above. To exclude low-quality reads and
reads mapping to murine DNA, the resulting 150 bp paired-end reads were
quality filtered with Trimmomatic v.0.3248 and mapped to the mouse
reference genome GRCm38 using Bowtie2 v.2.3.049. The high-quality
non-murine reads were taxonomically profiled using MetaPhlAn2 and
functionally profiled using HUMAnN2. Associations of microbial
and pathway abundances with genetics (C3−/− versus wildtype mice)
and demographic parameters (group, sex, and week at collection)
were identified by MaAsLin (for details see above). All animal studies
were conducted at the University of Bern and approved by the
local Animal Ethics Committee (Veterinärdienst des Kantons Bern/BE99-16).
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
The data sets supporting the conclusions of this article are available in the European
Nucleotide Archive under accession numbers PRJEB24557, PRJEB35615, and
PRJEB38145.
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CODE AVAILABILITY
Code for taxonomical analysis using MetaPhlAn2 v.2.6.0 with description for
installation is freely available at https://github.com/biobakery/MetaPhlAn. Code for
functional annotation using HUMAnN2 v.0.11.05 with description for installation is
freely available at https://github.com/biobakery/humann. Code for association
studies using MaAsLin2 is available at https://github.com/biobakery/Maaslin2. R
codes used for PCA by the package ade4 is described at http://www.sthda.com/
english/articles/31-principal-component-methods-in-r-practical-guide/119-pca-in-r-
using-ade4-quick-scripts/, machine learning approaches by sda are described at
https://rdrr.io/cran/sda/man/sda.html. More detailed informations are found in the
“Methods” section and available upon request by the corresponding author.
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